연구성과로 돌아가기
2023 연구성과별 연구자 정보 (719 / 2675)
※ 현재 Web of Science 저자 정보만 집계되어 있습니다.
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Document Title | Author Full Name | Author Short Name | Index | Corresponding | Address | ResearcherID | ResearcherID Author Name | ORCID | ORCID Author Name | Related Email |
|---|---|---|---|---|---|---|---|---|---|---|
| Dual anti-angiogenic and anti-metastatic activity of myriocin synergistically enhances the anti-tumor activity of cisplatin | Ojha, Uttam | Ojha, U | 2 | Kyungpook Natl Univ, Coll Pharm, Natl Basic Res Lab Vasc Homeostasis Regulat, 80 Daehakro, Daegu 41566, South Korea | 0000-0002-2938-5595 | Ojha, Uttam | lym@knu.ac.kr; | |||
| Dual anti-angiogenic and anti-metastatic activity of myriocin synergistically enhances the anti-tumor activity of cisplatin | Ojha, Uttam | Ojha, U | 2 | Kyungpook Natl Univ, Coll Pharm, 80 Daehakro, Daegu 41566, South Korea | 0000-0002-2938-5595 | Ojha, Uttam | lym@knu.ac.kr; | |||
| Dual anti-angiogenic and anti-metastatic activity of myriocin synergistically enhances the anti-tumor activity of cisplatin | Jang, Hyeonha | Jang, H | 3 | Kyungpook Natl Univ, Vessel Organ Interact Res Ctr VOICE MRC, Daegu 41566, South Korea | lym@knu.ac.kr; | |||||
| Dual anti-angiogenic and anti-metastatic activity of myriocin synergistically enhances the anti-tumor activity of cisplatin | Jang, Hyeonha | Jang, H | 3 | Kyungpook Natl Univ, Coll Pharm, Natl Basic Res Lab Vasc Homeostasis Regulat, 80 Daehakro, Daegu 41566, South Korea | lym@knu.ac.kr; | |||||
| Dual anti-angiogenic and anti-metastatic activity of myriocin synergistically enhances the anti-tumor activity of cisplatin | Jang, Hyeonha | Jang, H | 3 | Kyungpook Natl Univ, Coll Pharm, 80 Daehakro, Daegu 41566, South Korea | lym@knu.ac.kr; | |||||
| Dual anti-angiogenic and anti-metastatic activity of myriocin synergistically enhances the anti-tumor activity of cisplatin | Kang, Soohyun | Kang, S | 4 | Kyungpook Natl Univ, Coll Pharm, Natl Basic Res Lab Vasc Homeostasis Regulat, 80 Daehakro, Daegu 41566, South Korea | lym@knu.ac.kr; | |||||
| Dual anti-angiogenic and anti-metastatic activity of myriocin synergistically enhances the anti-tumor activity of cisplatin | Kang, Soohyun | Kang, S | 4 | Kyungpook Natl Univ, Coll Pharm, 80 Daehakro, Daegu 41566, South Korea | lym@knu.ac.kr; | |||||
| Dual anti-angiogenic and anti-metastatic activity of myriocin synergistically enhances the anti-tumor activity of cisplatin | Lee, Sunhee | Lee, S | 5 | Kyungpook Natl Univ, Vessel Organ Interact Res Ctr VOICE MRC, Daegu 41566, South Korea | C-9016-2011 | Lee, Kyung-Soo | lym@knu.ac.kr; | |||
| Dual anti-angiogenic and anti-metastatic activity of myriocin synergistically enhances the anti-tumor activity of cisplatin | Lee, Sunhee | Lee, S | 5 | Kyungpook Natl Univ, Coll Pharm, 80 Daehakro, Daegu 41566, South Korea | C-9016-2011 | Lee, Kyung-Soo | lym@knu.ac.kr; | |||
| Dual anti-angiogenic and anti-metastatic activity of myriocin synergistically enhances the anti-tumor activity of cisplatin | Lee, You Mie | Lee, YM | 6 | 교신저자 | Kyungpook Natl Univ, Vessel Organ Interact Res Ctr VOICE MRC, Daegu 41566, South Korea | lym@knu.ac.kr; | ||||
| Dual anti-angiogenic and anti-metastatic activity of myriocin synergistically enhances the anti-tumor activity of cisplatin | Lee, You Mie | Lee, YM | 6 | 교신저자 | Kyungpook Natl Univ, Coll Pharm, Natl Basic Res Lab Vasc Homeostasis Regulat, 80 Daehakro, Daegu 41566, South Korea | lym@knu.ac.kr; | ||||
| Dual anti-angiogenic and anti-metastatic activity of myriocin synergistically enhances the anti-tumor activity of cisplatin | Lee, You Mie | Lee, YM | 6 | 교신저자 | Kyungpook Natl Univ, Coll Pharm, 80 Daehakro, Daegu 41566, South Korea | lym@knu.ac.kr; | ||||
| Dual biologic or small molecules therapy in refractory paediatric inflammatory bowel disease (DOUBLE-PIBD): A multi-center study from the paediatric IBD Porto group of ESPGHAN | Cohen, S. | Cohen, S | 1 | Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Pediat Gastroenterol Inst, Tel Aviv, Israel | ||||||
| Dual biologic or small molecules therapy in refractory paediatric inflammatory bowel disease (DOUBLE-PIBD): A multi-center study from the paediatric IBD Porto group of ESPGHAN | Cohen, S. | Cohen, S | 1 | Tel Aviv Univ, Pediat Gastroenterol Inst, Sackler Fac Med, Tel Aviv, Israel | ||||||
| Dual biologic or small molecules therapy in refractory paediatric inflammatory bowel disease (DOUBLE-PIBD): A multi-center study from the paediatric IBD Porto group of ESPGHAN | Olbjorn, C. | Olbjorn, C | 2 | Akershus Univ Hosp, Dept Paediat & Adolescent Med, Lorenskog, Norway |
페이지 이동: